Royal Philips Electronics Announced the euHeart Project

Article of the Month!

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG; AEX: PHI) announced that it will lead a new European Union (EU) funded research project called euHeart, which is aimed at improving the diagnosis, therapy planning and treatment of cardiovascular disease - one of the biggest causes of mortality in the western world.

By targeting the diagnosis and treatment phases of the care cycles for heart conditions such as heart failure, coronary artery disease, heart rhythm disorders, and congenital heart defects, the euHeart project complements the recently announced HeartCycle project, also led by Philips, which focuses on the long term management of chronic heart disease patients.

The euHeart consortium aims to develop advanced computer models of the human heart that can be personalized to patient-specific conditions using clinical data from various sources, such as CT (Computed Tomography) and MRI (Magnetic Resonance Imaging) scans, measurements of blood flow and blood pressure in the coronary arteries (which feed the heart muscles) and ECGs (Electrocardiograms).

These computer models will integrate the behavior of the heart and the aorta at molecular, cellular, tissue and organ-level. They will also incorporate clinical knowledge about how cardiovascular disease disturbs the correct functioning of the heart at these levels. As a result, it may be possible to develop simulation tools that doctors can use to predict the outcome of different types of therapy, and because the models will be personalized to individual patients, the therapy could be equally personalized.

"euHeart is a very exciting project that will bring together the latest advances in modeling and computing to improve the care of patients with heart disease," says Professor Reza Razavi, the Project's Clinical Coordinator who is also Professor of Paediatric Cardiovascular Science and Head of the Division of Imaging Sciences at King’s College London (London, United Kingdom). "It may ultimately allow us to select and optimize the best treatment for individual patients."

As an example, one way of treating heart rhythm disorders is a minimally invasive procedure known as radio-frequency ablation. During this procedure, a catheter is inserted into the patient’s heart and the tissue responsible for propagating abnormal electrical signals through the heart muscle is destroyed using heat from a radio-frequency field generated at the tip of the catheter. At the moment, doctors have to rely on their experience to decide which areas of tissue to destroy – a task that is complicated by the fact that the electrical activity in every patient's heart is subtly different. With the aid of a computerized model that reflects the patient's unique heart structure and function, doctors may be able to test the results of destroying different areas of tissue before they have to operate on the patient.

"The development of computer models that integrate structural and functional information of the heart and then personalize it to individual patients is a mammoth task that will require the multi-disciplinary effort of researchers with strong know-how in biophysical modeling and image processing, clinical experts, and engineers in the device and imaging industries," commented Henk van Houten, senior vice president of Philips Research and head of the Healthcare Research program. "In the euHeart project we are confident that we have brought together the necessary expertise and that we can make a real contribution to improving the treatment of one of the world's killer diseases."

The euHeart consortium comprises public and private partners from 16 research, academic, industrial and medical organizations from six different European countries. It will run for four years and has a budget of approximately EUR 19 million, of which approximately EUR 14 million will be provided by the European Union as part of the EU 7th Framework Program. The project forms part of the Virtual Physiological Human (VPH) initiative - a collaborative effort that aims to produce a computer model of the entire human body so that it can be investigated as a single complex system.

Within the multidisciplinary euHeart consortium, the University of Oxford (Oxford, UK) is the scientific coordinator of the project, while King's College London (London, UK) leads the clinical program.

euHeart Consortium membership (in alphabetical order):
Academic Medical Center Amsterdam (Netherlands); Berlin Heart (Germany); Deutsches Krebsforschungszentrum (Germany); HemoLab (Netherlands); Hospital Clínico San Carlos de Madrid Insalud (Spain); Institut National de la Santé et de la Recherche Médicale (France); Institut National de Recherche en Informatique et en Automatique (France): King's College London (United Kingdom); Philips Healthcare (Netherlands, Spain); Philips Research (Germany); PolyDimensions (Germany); Universitat Pompeu Fabra (Spain); University of Karlsruhe (Germany); University of Oxford (United Kingdom); University of Sheffield (United Kingdom); Volcano Europe SA/NV (Belgium).

Related news articles:

More information on the euHeart project:
http://www.research.philips.com/newscenter/
backgrounders/080820-euheart.html

More information on the parallel HeartCycle project:
http://www.research.philips.com/technologies/
healthcare/homehc/heartcycle/heartcycle-gen.html

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 133,000 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2007, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...